Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Oxford Biomedica Appoints Frank Mathias as CEO (2022-11-22)
Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a leading gene and cell therapy group, today announces the appointment of Dr Frank Mathias as Chief Executive Officer (CEO) and Board Director, effective March 2023. Dr Mathias brings world-cl...
Catalym Closes €50m Series C Led by Brandon Capital & Jeito (2022-11-22)
CatalYm today announced the close of a EUR 50 million (USD 49 million) Series C financing round. The oversubscribed round was co-led by new investors, Brandon Capital and Jeito Capital with participation from existing investors Forbion, Novartis Venture Fund, Vesal...
Uniqure & CSL: FDA Approves Gene Therapy for Hemophilia B (2022-11-22)
> Historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy, and generates elevated and sustained factor IX levels > uniQure conducted the multi-year clinical development pro...
Accession Therapeutics Raises £16.6m Financing Round (2022-11-21)
New Singaporean investor iGlobe Partners backs rapidly developing preclinical pipeline at immunotherapy pioneer’s company Accession Therapeutics, which is developing novel immuno-oncology therapeutics combining high specificity and potency with the ability to ...
FogPharma Announces $178m Series D Financing Round (2022-11-21)
> Helicon polypeptide therapeutics are a new class of drugs designed to address the limitations of today’s precision medicines and ultimately achieve universal druggability > FOG-001, a first-in-class direct TCF-blocking ß-catenin inhibitor with potential applic...
Cradle Bio Emerges from Stealth with €5.5m in Seed Funding (2022-11-17)
> Cradle’s design platform makes it easy for everyone to start building products with biology instead of oil or animals, leveraging generative machine learning models to transform how biologists design and optimize proteins > Synthetic biology can generate envir...
Valneva Appoints Dipal Patel as Chief Commercial Officer (2022-11-17)
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the appointment of Dipal Patel as Chief Commercial Officer (CCO) and Management Board member. With this newly created role, Valneva strengthens its management team with a r...
Sarcura GmbH Secures € 7M Seed Plus Funding Round (2022-11-17)
The Austrian deep tech startup Sarcura closes an oversubscribed €7M Seed Plus funding round to develop a next-generation cell therapy manufacturing platform. The round was co-led by seed investors Lansdowne Investment Company Cyprus and IST Cube with participati...
Kriya Therapeutics Acquires Redpin Therapeutics (2022-11-16)
Kriya Therapeutics, Inc., a fully integrated gene therapy company advancing a broad portfolio of innovative therapeutics, today announced the acquisition of Redpin Therapeutics, Inc., a privately held biotechnology company developing regulatable gene therapies for ...
Novigenix SA: First Closing of $20m Series B Financing Round (2022-11-16)
Expansion of Biopharma precision solutions in the field of Immuno-Oncology Novigenix SA, a leading data-driven precision medicine biotech that develops and commercializes Immuno-Transcriptomic precision oncology solutions, today announced successful first clos...

» Show all News!

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

» Start here with the latest News!

Picture Campus Berlin-Buch GmbH GMP Basic Course Online 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]